{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:52:49Z","timestamp":1771980769721,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ygyno.2022.01.026","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T17:31:43Z","timestamp":1646674303000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer"],"prefix":"10.1016","volume":"165","author":[{"given":"Julia","family":"Chalif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Gruner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Kuznicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Michener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"DeBernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2022.01.026_bb0005","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2022.01.026_bb0010","series-title":"Cancer Stat Facts: Ovarian Cancer","author":"Surveillance, Epidemiology, and End Results Program","year":"2021"},{"key":"10.1016\/j.ygyno.2022.01.026_bb0015","series-title":"NCCN Clinical Practice Guideline in Oncology: Ovarian Cancer including Fallopian Tube Cancer and Primary Peritoneal Cancer. Version 1.20","article-title":"et al","author":"Armstrong","year":"2021"},{"key":"10.1016\/j.ygyno.2022.01.026_bb0020","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e58","article-title":"Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands","volume":"31","author":"Burg","year":"2020","journal-title":"J.Gynecol.Oncol."},{"key":"10.1016\/j.ygyno.2022.01.026_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10585-019-10007-0","article-title":"Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes","volume":"37","author":"Gardner","year":"2020","journal-title":"Clin.Exp.Metastasis."},{"key":"10.1016\/j.ygyno.2022.01.026_bb0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ygyno.2020.03.003","article-title":"Prognostic value of radiological recurrence patterns in ovarian cancer","volume":"157","author":"Roze","year":"2020","journal-title":"Gynecol.Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.01.026_bb0035","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ygyno.2018.06.022","article-title":"Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients","volume":"150","author":"Deng","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.01.026_bb0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1477-7819-11-255","article-title":"Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma","volume":"11","author":"Chen","year":"2013","journal-title":"World J Surg Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2022.01.026_bb0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/IGC.0b013e3181e833f5","article-title":"Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer","volume":"20","author":"Kolev","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2022.01.026_bb0050","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/ijgc-2019-000829","article-title":"Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer","volume":"29","author":"Cybulska","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2022.01.026_bb0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2017.07.124","article-title":"Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB?","volume":"147","author":"Nasioudis","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.01.026_bb0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","article-title":"2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer","volume":"133","author":"Mutch","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.01.026_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1757-2215-7-20","article-title":"Ovarian cancer initially presenting with isolated ipsilateral superficial inguinal lymph node metastasis: a case study and review of the literature","volume":"7","author":"Yang","year":"2014","journal-title":"J Ovarian Res"},{"issue":"6","key":"10.1016\/j.ygyno.2022.01.026_bb0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.47102\/annals-acadmedsg.V36N6p427","article-title":"Ovarian carcinoma presenting with isolated contralateral inguinal lymph node metastasis: a case report","volume":"36","author":"Ang","year":"2007","journal-title":"Ann. Acad. Med. Singap."},{"issue":"2","key":"10.1016\/j.ygyno.2022.01.026_bb0075","first-page":"385","article-title":"Normal size ovary carcinoma syndrome with inguinal ovarian Cancer lymph node metastases - a case report and literature review","volume":"32","author":"Bacalbasa","year":"2018","journal-title":"In Vivo."},{"issue":"4","key":"10.1016\/j.ygyno.2022.01.026_bb0080","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s13193-016-0556-7","article-title":"Presentation and management of inguinal lymphadenopathy in ovarian cancer","volume":"7","author":"Giri","year":"2016","journal-title":"Indian J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.01.026_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jnci.2017.01.003","article-title":"Ovarian cancer with metastatic inguinal lymphadenopathy: a case series and literature review","volume":"29","author":"Metwally","year":"2017","journal-title":"J Egypt Natl Canc Inst."},{"issue":"3","key":"10.1016\/j.ygyno.2022.01.026_bb0090","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ygyno.2015.09.022","article-title":"Isolated inguinal node recurrences of ovarian cancer: a case series study","volume":"139","author":"Emerson","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2022.01.026_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J.Biomed.Inform."},{"key":"10.1016\/j.ygyno.2022.01.026_bb0100","first-page":"1","article-title":"Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy","volume":"2","author":"Plentl","year":"1971","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2022.01.026_bb0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/beog.2002.0301","article-title":"Role of lymphadenectomy in ovarian cancer","volume":"16","author":"Panici","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"issue":"7","key":"10.1016\/j.ygyno.2022.01.026_bb0110","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/1097-0142(19891001)64:7<1508::AID-CNCR2820640725>3.0.CO;2-V","article-title":"Metastatic patterns in histologic variants of ovarian cancer. An autopsy study","volume":"64","author":"Rose","year":"1989","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.ygyno.2022.01.026_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0046-8177(88)80316-2","article-title":"Distribution of disease at autopsy in 100 women with ovarian cancer","volume":"19","author":"Dvoretsky","year":"1988","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2022.01.026_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1757-2215-7-20","article-title":"Ovarian cancer initially presenting with isolated ipsilateral superficial inguinal lymph node metastasis: a case study and review of the literature","volume":"7","author":"Yang","year":"2014","journal-title":"J Ovarian Res"},{"issue":"6","key":"10.1016\/j.ygyno.2022.01.026_bb0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.47102\/annals-acadmedsg.V36N6p427","article-title":"Ovarian carcinoma presenting with isolated contralateral inguinal lymph node metastasis: a case report","volume":"36","author":"Ang","year":"2007","journal-title":"Ann. Acad. Med. Singap."},{"issue":"2","key":"10.1016\/j.ygyno.2022.01.026_bb0130","first-page":"385","article-title":"Normal size ovary carcinoma syndrome with inguinal ovarian Cancer lymph node metastases - a case report and literature review","volume":"32","author":"Bacalbasa","year":"2018","journal-title":"In Vivo."},{"issue":"4","key":"10.1016\/j.ygyno.2022.01.026_bb0135","first-page":"436","article-title":"Presentation and Management of Inguinal Lymphadenopathy in ovarian Cancer. Indian","volume":"7","author":"Giri","year":"2016","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2022.01.026_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jnci.2017.01.003","article-title":"Ovarian cancer with metastatic inguinal lymphadenopathy: a case series and literature review","volume":"29","author":"Metwally","year":"2017","journal-title":"J Egypt Natl Canc Inst."},{"issue":"10","key":"10.1016\/j.ygyno.2022.01.026_bb0150","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2022.01.026_bb0155","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","article-title":"Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease","volume":"17","author":"Wimberger","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2022.01.026_bb0160","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ajog.2017.05.036","article-title":"BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study","volume":"217","author":"Petrillo","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2022.01.026_bb0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ygyno.2011.09.011","article-title":"Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer","volume":"124","author":"Tanner","year":"2012","journal-title":"Gynecol.Oncol."},{"key":"10.1016\/j.ygyno.2022.01.026_bb0170","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ygyno.2020.03.003","article-title":"Prognostic value of radiological recurrence patterns in ovarian cancer","volume":"157","author":"Roze","year":"2020","journal-title":"Gynecol.Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:56Z","timestamp":1758772856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0090825822000658"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.01.026","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}